[HTML][HTML] Insights from deep sequencing of the HBV genome—unique, tiny, and misunderstood

AL McNaughton, V D'Arienzo, MA Ansari, SF Lumley… - Gastroenterology, 2019 - Elsevier
Hepatitis B virus (HBV) is a unique, tiny, partially double-stranded, reverse-transcribing DNA
virus with proteins encoded by multiple overlapping reading frames. The substitution rate is …

Phylogeny and molecular evolution of the hepatitis C virus

P Jackowiak, K Kuls, L Budzko, A Mania… - Infection, Genetics and …, 2014 - Elsevier
The hepatitis C virus (HCV) is a globally prevalent human pathogen that causes persistent
liver infections in most infected individuals. HCV is classified into seven phylogenetically …

HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy

CN Hayes, M Kobayashi, N Akuta, F Suzuki, H Kumada… - Gut, 2011 - gut.bmj.com
Background and aims A number of recent studies have shown that human polymorphisms
near the IL28B type III interferon (IFNλ) gene influence the response to peg-interferon plus …

Analysis of HCV quasispecies dynamic under selective pressure of combined therapy

ACG Jardim, C Bittar, RPA Matos, LHT Yamasaki… - BMC infectious …, 2013 - Springer
Background The quasispecies composition of Hepatitis C virus (HCV) could have important
implications with regard to viral persistence and response to interferon-based therapy. The …

Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection

P Rahimi, H Sharafi, G Bahramali… - Frontiers in …, 2021 - frontiersin.org
Background Hepatitis C virus (HCV), non-structural 5A (NS5A), and non-structural 5B
(NS5B) resistance-associated substitutions (RASs) are the main causes of failure to direct …

New insights regarding HCV-NS5A structure/function and indication of genotypic differences

LHT Yamasaki, HA Arcuri, ACG Jardim, C Bittar… - Virology journal, 2012 - Springer
Background HCV is prevalent throughout the world. It is a major cause of chronic liver
disease. There is no effective vaccine and the most common therapy, based on …

On hepatitis C virus evolution: the interaction between virus and host towards treatment outcome

C Bittar, ACG Jardim, LHT Yamasaki, CMA Carareto… - PLoS …, 2013 - journals.plos.org
Background Hepatitis C is a disease spread throughout the world. Hepatitis C virus (HCV),
the etiological agent of this disease, is a single-stranded positive RNA virus. Its genome …

The relationships between IFNL4 genotype, intrahepatic interferon‐stimulated gene expression and interferon treatment response differs in HCV‐1 compared with …

JA Holmes, M Congiu, S Bonanzinga… - Alimentary …, 2015 - Wiley Online Library
Background The biological mechanism underlying the association between IFNL4/IFNL3
polymorphism and peginterferon/ribavirin (PR) response in HCV‐1 is thought to involve …

Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein

I Ali, S Khan, S Attaullah, SN Khan, J Khan, S Siraj… - Virology Journal, 2011 - Springer
Abstract Background Hepatitis C virus (HCV) genotype 3a is known to show comparatively
better response to combination therapy than genotype 1 and 4. Mutations within NS5A gene …

Copy number variation of genes involved in the hepatitis C virus-human interactome

L Budzko, M Marcinkowska-Swojak, P Jackowiak… - Scientific Reports, 2016 - nature.com
Copy number variation (CNV) is a newly discovered form of intra-species genetic
polymorphism that is defined as deletions or duplications of genome segments ranging from …